PET imaging of tumours with a64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate

Imaging of hypoxia with18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy

(2013) Mateya E Trinkaus et al.   Journal of Medical Imaging and Radiation Oncology

Preparation and Biological Evaluation of 64Cu Labeled Tyr3-Octreotate Using a Phosphonic Acid-Based Cross-Bridged Macrocyclic Chelator

(2012) Yunjun Guo et al.   BIOCONJUGATE CHEMISTRY

Tumour targeting of Auger emitters using DNA ligands conjugated to octreotate

(2012) Pavel Lobachevsky et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study

(2012) A. Pfeifer et al.   JOURNAL OF NUCLEAR MEDICINE

Gallium-68 Complex of a Macrobicyclic Cage Amine Chelator Tethered to Two Integrin-Targeting Peptides for Diagnostic Tumor Imaging

(2011) Michelle T. Ma et al.   BIOCONJUGATE CHEMISTRY

Challenges in chelating positron emitting copper isotopes: tailored synthesis of unsymmetric chelators to form ultra stable complexes

(2011) Jon D. Silversides et al.   DALTON TRANSACTIONS

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy

(2011) Jean-Mathieu Beauregard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Macrobicyclic Cage Amine Ligands for Copper Radiopharmaceuticals: A Single Bivalent Cage Amine Containing Two Lys3-bombesin Targeting Peptides

(2011) Michelle T. Ma et al.   INORGANIC CHEMISTRY

Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment

(2011) H. R. Maecke et al.   JOURNAL OF NUCLEAR MEDICINE

In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor-Expressing Prostate Cancer

(2011) K. A. Lears et al.   JOURNAL OF NUCLEAR MEDICINE

PET of Somatostatin Receptor-Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference

(2011) M. Fani et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy

(2011) Kim Nguyen et al.   NUCLEAR MEDICINE AND BIOLOGY

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy

(2011) R.J. Hicks   CANCER IMAGING

Evaluation of Copper-64 Labeled AmBaSar Conjugated Cyclic RGD Peptide for Improved MicroPET Imaging of Integrin αvβ3Expression

(2010) Hancheng Cai et al.   BIOCONJUGATE CHEMISTRY

Long tailed cage amines: Synthesis, metal complexation, and structure

(2010) Birger Dittrich et al.   DALTON TRANSACTIONS

Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody

(2010) Jason L.J. Dearling et al.   NUCLEAR MEDICINE AND BIOLOGY

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

(2010) Dik J. Kwekkeboom et al.   SEMINARS IN NUCLEAR MEDICINE

Variations on a Cage Theme: Some Complexes of Bicyclic Polyamines as Supramolecular Synthons

(2009) Ian J. Clark et al.   AUSTRALIAN JOURNAL OF CHEMISTRY

A new bifunctional chelator for copper radiopharmaceuticals: a cage amine ligand with a carboxylate functional group for conjugation to peptides

(2009) Michelle T. Ma et al.   CHEMICAL COMMUNICATIONS

Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and 64Cu radiolabelling

(2009) Hancheng Cai et al.   DALTON TRANSACTIONS

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY